Active Cells, Biochemistry & Physiology Genetics & Molecular Biology

New horizons in hypoxia signalling

In plain English

AI plain-English summary

Every living cell needs oxygen to function, and when oxygen levels drop—during a heart attack, stroke, or even a high-altitude climb—the body must respond in seconds, not minutes. Scientists already know one major oxygen-sensing system, called HIF/PHD, but it works by switching genes on and off, which is too slow to explain the body’s instant reflexes to low oxygen. This project investigates a newly discovered, faster oxygen-sensing system in human cells. It centres on an enzyme called ADO, which directly modifies signalling proteins and marks them for destruction when oxygen is present—a process that can happen far more quickly than gene-based responses. The researchers will identify which proteins ADO targets, how this system interacts with the slower HIF/PHD pathway, and whether it helps excitable cells like neurons fire rapid electrical signals in response to oxygen changes. If successful, this work will rewrite the textbook understanding of how the body maintains oxygen balance. It is fundamental science, not a therapy in development. But past discoveries in oxygen sensing have already led to drugs for anaemia and cancer. A deeper grasp of this second, faster system could eventually open new routes for treating conditions where oxygen supply is suddenly compromised—stroke, heart attack, or respiratory failure.

View original technical description
Oxygen homeostasis is central to most forms of life and its breakdown complicates most human diseases. Although regulation of the HIF transcriptional cascade by oxygen-dependent prolyl hydroxylation (HIF/PHD system) has provided important insights, it cannot, alone, deliver the precision implicit in physiological oxygen homeostasis, particularly rapid responses that are inconsistent with dependence on new transcription. We will define the physiological role of a new system of human oxygen sensing, recently identified in this laboratory, which directly regulates signalling intermediates by N-Cys dioxygenation coupled to N-degron mediated proteolysis, an oxygen sensitive reaction catalysed by cysteamine (2-aminoethanethiol) dioxygenase (ADO). We will define the range of substrates of ADO and their role in the physiology of oxygen homeostasis. We will determine how the HIF/PHD and ADO/N-Cys systems interact, including their interactions with oxygen chemoreceptor mechanisms that transduce rapid electrophysiological responses to hypoxia in excitable cells. The work aims to provide new insights into the mechanism(s) of chemosensitivity and new systems for its study. Our aim is to deliver new paradigms in the understanding of hypoxia signalling, which will have broad relevance to medical physiology, offer new entry points for medicine discovery and deliver new resources to the research community.

View the original record at the funder ↗

Researchers

Matthew Cockman (EPMC Awardee)Peter Ratcliffe (EPMC Awardee)Tammie Bishop (EPMC Awardee)Tom Keeley (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Exploring the molecular interface between the HIF/hypoxia signalling pathway and mitochondria in cancer
Biophysical and biological characterization of FIH-catalysed post-translational asparaginyl hydroxylation.
The interplay between the oxygen sensors PHDs and the cell cycle
Hypoxic and normoxic activation of NF-kappaB and HIF: investigating their crosstalk in a coordinated cellular response
Functional assignments on human oxygenases

Original classification

Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.